DeepMed Research

Avita Medical

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Employees: 207

Market Cap: -

Website: http://www.avitamedical.com

Introduction: AVITA Medical, Inc., through its subsidiaries, engages in the development and and commercialization of medical devices used in regenerative medicine. The company is headquartered in Valencia, CA.

Clinical Trials

Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds

Not Applicable

Recruiting

Conditions: Burn
Trauma Wound
Full Thickness Wounds
Surgical Wound

First Posted Date: 2025-01-22

Last Posted Date: 2025-04-20

Lead Sponsor: Avita Medical

Target Recruit Count: 40

Registration Number: NCT06787690

Locations: 🇺🇸
University of South Alabama, Mobile, Alabama, United States
🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸
University Medical Center, New Orleans, Louisiana, United States

and more 7 locations

Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds

Not Applicable

Recruiting

Conditions: Surgical Wound
Trauma Wound
Autografts
Partial-thickness Burn
Partial Thickness Wounds

First Posted Date: 2024-12-27

Last Posted Date: 2025-04-22

Lead Sponsor: Avita Medical

Target Recruit Count: 40

Registration Number: NCT06750809

Locations: 🇺🇸
Grady Memorial, Atlanta, Georgia, United States
🇺🇸
University Medical Center, New Orleans, Louisiana, United States
🇺🇸
University of Rochester, Rochester, New York, United States

and more 6 locations

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Not Applicable

Completed

Conditions: Vitiligo

Interventions: Device: RECELL® Autologous Cell Harvesting Device

First Posted Date: 2023-08-02

Last Posted Date: 2025-02-06

Lead Sponsor: Avita Medical

Target Recruit Count: 109

Registration Number: NCT05971381

Locations: 🇺🇸
University Of Massachusetts, Worcester, Massachusetts, United States
🇺🇸
Affiliated Dermatology, Scottsdale, Arizona, United States
🇺🇸
University of California, Irvine, Irvine, California, United States

and more 14 locations

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

Not Applicable

Completed

Conditions: Vitiligo

Interventions: Device: Control Intervention (UVB)
Device: Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB)

First Posted Date: 2020-09-14

Last Posted Date: 2024-05-24

Lead Sponsor: Avita Medical

Target Recruit Count: 25

Registration Number: NCT04547998

Locations: 🇺🇸
Heights Dermatology, Houston, Texas, United States
🇺🇸
Skin Care Research, LLC, Hollywood, Florida, United States
🇺🇸
DMR Research, Westport, Connecticut, United States

and more 9 locations

Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

Not Applicable

Terminated

Conditions: Vitiligo

Interventions: Procedure: Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB)

First Posted Date: 2020-02-17

Last Posted Date: 2023-03-14

Lead Sponsor: Avita Medical

Target Recruit Count: 5

Registration Number: NCT04271501

Locations: 🇺🇸
University of Massachusetts, Worcester, Massachusetts, United States

RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction

Not Applicable

Completed

Conditions: Gun Shot Wound
Skin Cancer
Full-thickness Skin Defects
Crush Injuries
Infection
Necrotizing Fasciitis
Degloving Injuries
Laceration of Skin
Surgical Wound
Cellulitis

Interventions: Procedure: Control Intervention (Conventional Autograft)
Device: Investigational Intervention (RECELL + more widely meshed autograft)

First Posted Date: 2019-09-17

Last Posted Date: 2024-07-30

Lead Sponsor: Avita Medical

Target Recruit Count: 65

Registration Number: NCT04091672

Locations: 🇺🇸
Cook County Health, Chicago, Illinois, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Kendall Regional Medical Center, Miami, Florida, United States

and more 15 locations

RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years

Not Applicable

Terminated

Conditions: Burns

Interventions: Device: RES (Regenerative Epidermal Suspension) prepared using the RECELL® Autologous Cell Harvesting Device
Combination Product: Mepilex® Ag Wound Dressing
Procedure: Conventional autografting (only when indicated)

First Posted Date: 2018-08-13

Last Posted Date: 2024-07-30

Lead Sponsor: Avita Medical

Target Recruit Count: 19

Registration Number: NCT03626701

Locations: 🇺🇸
Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
🇺🇸
University Medical Center New Orleans, New Orleans, Louisiana, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

and more 6 locations

RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years

Not Applicable

Terminated

Conditions: Skin; Deformity

Interventions: Other: Telfa™ Clear and Xeroform™ dressings
Device: RECELL® Autologous Cell Harvesting Device

First Posted Date: 2018-08-10

Last Posted Date: 2024-07-18

Lead Sponsor: Avita Medical

Target Recruit Count: 3

Registration Number: NCT03624192

Locations: 🇺🇸
University of Washington Regional Burn Center at Harborview Medical Center, Seattle, Washington, United States
🇺🇸
University of California at San Diego, San Diego, California, United States
🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

and more 4 locations

Continued Access to the Recell® Device for Treatment of Acute Burn Injuries

Completed

Conditions: Burns

Interventions: Device: ReCell® Autologous Cell Harvesting Device

First Posted Date: 2017-11-07

Last Posted Date: 2024-07-30

Lead Sponsor: Avita Medical

Target Recruit Count: 76

Registration Number: NCT03333941

Locations: 🇺🇸
University of Tennessee Health Science Center, Memphis, Tennessee, United States
🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
Arizona Burn Center at Maricopa Integrated Health Systems, Phoenix, Arizona, United States

and more 3 locations

CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries

Not Applicable

Completed

Conditions: Burns

Interventions: Device: ReCell

First Posted Date: 2016-12-16

Last Posted Date: 2024-07-30

Lead Sponsor: Avita Medical

Target Recruit Count: 12

Registration Number: NCT02994654

Locations: 🇺🇸
U.S.Army Institute of Surgical Research, Fort Sam Houston, Texas, United States
🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
Arizona Burn Center at Maricopa Integrated Health Systems, Phoenix, Arizona, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy